Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Exp Cell Res ; 308(2): 273-82, 2005 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-15936757

RESUMO

In this work, we isolated and produced long-term cultures of human fetal endothelial cells (fECs) deriving from different organs of the same 12-week-old embryos. Highly pure endothelium cultures were obtained from specimens of brain, heart, lung, liver, aorta and kidney by using magnetic microspheres coated with CD31 or CD34 specific endothelial antibodies. The endothelial nature of these cells was confirmed by the presence of von Willebrand Factor (vWf), Flk-1/VEGFR2 and CD31. The fECs cultures showed organ-specific differences as regards to the morphological appearance, the growth rate and the expression of cellular adhesion molecules (CAMs) before or after stimulation by the inflammatory cytokines IL-1beta and TNF-alpha. For instance, TNF-alpha showed a specific effect on fetal heart ECs by stimulating E-selectin expression. Our findings indicate that fECs may represent an innovative tool to study differences among ECs of different vascular districts of the same individual, thus increasing the possibility to compare many pathological aspects of human adult and fetal microvasculature.


Assuntos
Moléculas de Adesão Celular/metabolismo , Endotélio Vascular/metabolismo , Microcirculação/embriologia , Neovascularização Fisiológica/fisiologia , Vísceras/irrigação sanguínea , Vísceras/embriologia , Antígenos de Superfície/imunologia , Biomarcadores/metabolismo , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Citocinas/farmacologia , Selectina E/metabolismo , Endotélio Vascular/citologia , Feto , Humanos , Microcirculação/imunologia , Microcirculação/metabolismo , Especificidade de Órgãos/fisiologia , Molécula-1 de Adesão Celular Endotelial a Plaquetas/metabolismo , Receptor 2 de Fatores de Crescimento do Endotélio Vascular/metabolismo , Fator de von Willebrand/metabolismo
2.
Br J Cancer ; 74(8): 1168-74, 1996 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8883400

RESUMO

The expression of urokinase-type plasminogen activator (uPA) was investigated in squamous cell carcinoma of the human larynx. For this purpose, tissue extracts from 25 matched samples of normal mucosa and neoplastic larynx were compared for the levels of uPA activity as evaluated by a chromogenic PA assay and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) zymography. Also, uPA antigen was quantified by enzyme-linked immunosorbent assay (ELISA) in 19 cases. The results demonstrate a significant increase in the levels of uPA activity and protein in tumour tissue extracts, more pronounced in tumours with lymph node metastases. Immunohistochemistry performed on 70 biopsies showed that uPA positivity is present both in neoplastic cells and in fibroblast-like cells and macrophages. However, depending on the histological grading and invasive capacity of the tumour, a pronounced intra- and intertumoral heterogeneity in uPA staining was observed. In situ hybridisation confirmed the presence of uPA mRNA in both tumour and stromal cells. The present study provides experimental evidence for a role of uPA in the invasive growth of human laryngeal carcinoma.


Assuntos
Carcinoma de Células Escamosas/enzimologia , Neoplasias Laríngeas/enzimologia , Regulação para Cima/fisiologia , Ativador de Plasminogênio Tipo Uroquinase/metabolismo , Antígenos de Neoplasias/metabolismo , Carcinoma de Células Escamosas/patologia , Humanos , Imuno-Histoquímica , Hibridização In Situ , Mucosa Laríngea/enzimologia , Neoplasias Laríngeas/patologia , Metástase Neoplásica , RNA Mensageiro/metabolismo , Valores de Referência
3.
Clin Ter ; 132(4): 229-33, 1990 Feb 28.
Artigo em Italiano | MEDLINE | ID: mdl-2140309

RESUMO

A clinical trial has been carried out in 40 children (age ranging from 2 to 12 years) with postsurgical infections caused by aerobic, anaerobic and facultative bacteria. All have been treated by monotherapy with sodium piperacillin, with doses of 150-200 mg/kg daily in 3 administrations. The drug was administered for a mean period of 7 days, by intravenous infusion or intramuscular route. The causative organism was eradicated in all but 4 cases (90%). Side effects observed were all of mild intensity, and in no case it was necessary to discontinue the treatment with the drug. Both bacterial and clinical results indicate a high tolerability and a very rapid effectiveness of this antibiotic.


Assuntos
Infecções Bacterianas/tratamento farmacológico , Piperacilina/uso terapêutico , Complicações Pós-Operatórias/tratamento farmacológico , Criança , Pré-Escolar , Ensaios Clínicos como Assunto , Esquema de Medicação , Avaliação de Medicamentos , Feminino , Humanos , Masculino , Piperacilina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...